Abstract:Autoimmune rheumatic diseases (AIRDs) with unknown etiology are increasing in incidence and prevalence. Up to 5% of the population is affected. AIRDs include rheumatoid arthritis, system lupus erythematosus, systemic sclerosis, and Sjögren’s syndrome. In patients with autoimmune diseases, the immune system attacks structures of its own body, leading to widespread tissue and organ damage, which, in turn, is associated with increased morbidity and mortality. One third of the mortality associated with autoimmune diseases is due to cardiovascular diseases. Atherosclerosis is considered the main underlying cause of cardiovascular diseases. Currently, because of finding macrophages and lymphocytes at the atheroma, atherosclerosis is considered a chronic immune-inflammatory disease. In active inflammation, the liberation of inflammatory mediators such as tumor necrotic factor alpha (TNFa), interleukine-6 (IL-6), IL-1 and other factors like T and B cells, play a major role in the atheroma formation. In addition, antioxidized, low-density lipoprotein (LDL) antibodies, antinuclear antibodies (ANA), and rheumatoid factor (RF) are higher in the atherosclerotic patients. Traditional risk factors like gender, age, hypercholesterolemia, smoking, diabetes mellitus, and hypertension, however, do not alone explain the risk of atherosclerosis present in autoimmune diseases. This review examines the role of chronic inflammation in the etiology—and progression—of atherosclerosis in autoimmune rheumatic diseases. In addition, discussed here in detail are the possible effects of autoimmune rheumatic diseases that can affect vascular function. We present here the current findings from studies that assessed vascular function changes using state-of-the-art techniques and innovative endothelial function biomarkers.

The Research Advance of the Relationship Between Autoimmunity and Cardiovascular Diseases

Relationship Between Autoantibodies Against Oxidized Low-Density Lipoprotein and High-Sensitivity C-reactive Protein in Patients with Coronary Artery Disease

The Role of Immunogenicity in Cardiovascular Disease.

Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies

Advances in Immunopathogenesis of Coronary Heart Disease and Hypertension

Research Progress of Immunity Mechanism in Hypertension

An updated advance of autoantibodies in autoimmune diseases

The Relationship between High-Sensitivity C-reactive Protein and Coronary Artery Disease

[Chronic Inflammation, Autoimmunity and Atherosclerosis].

Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy.

Immunomodulatory Mechanism of Coronary Heart Disease and Related Therapeutic Applications and Prospects

Cardiovascular Risk in Autoimmune Disorders: Role of Asymmetric Dimethylarginine

The Role of CXC Chemokines in Cardiovascular Diseases

Therapeutic Effect and Mechanism of Acupuncture in Autoimmune Diseases

Cardiovascular risk in autoimmune disorders: role of asymmetric dimethylarginine.

Cardiovascular Disease in Patients with Type 1 Diabetes: Early Evaluation, Risk Factors and Possible Relation with Cardiac Autoimmunity.

Progress in Research on the Role of Exosomal Mirnas in the Diagnosis and Treatment of Cardiovascular Diseases

Autoimmune Diseases and Fungal Infections: Immunological Mechanisms and Therapeutic Approaches.

Autoimmune Diseases and Cardiovascular Risk: Mendelian Randomization Analysis for the Impact of 19 Autoimmune Diseases on 14 Cardiovascular Conditions

Main biologics for anti-autoimmune disease:research advances

Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis